NCT01602107

Brief Summary

Urinary incontinence (UI) affects up to 50% of adult populations and stress urinary incontinence (SUI) is the most common form of UI, accounting for approximately 60% of patients. Women are affected by SUI much more often than men. Urine leakage in women with SUI occurs on exertion or during tasks that increase pressure on the bladder such as sneezing or coughing. SUI has been shown to be a barrier to physical activity in women, and as such can contribute to the development of diseases and disorders associated with inactivity. SUI appears to have many contributing factors such as structural damage (eg. tears in the pelvic organ supporting tissues), muscle weakness related to nerve injury or aging, or thinning of the urethral wall and/or its surrounding muscular sphincters. Currently the most common treatments for SUI are conservative therapy, which normally takes the form of exercise therapy provided by specialized nurses or physical therapists, and surgery, which is aimed at enhancing urethral support. Exercise therapy is effective, resulting in complete cure in 50% of cases, and surgery is effective for approximately 80% of patients but carries risks such as the development of urinary retention. It is currently not clear which treatment approach is better for which women. Through the proposed research, the investigators aim to determine how to predict which patients will improve or be cured with exercise therapy such that surgery can be avoided. Specifically the investigators will determine what is different between patients in whom exercise therapy succeeds and in whom exercise therapy fails. The investigators will also determine whether physiotherapist-supervised training of the pelvic floor muscles before surgery improves surgical outcomes. The proposed research will enable us to better understand the female continence system and how it responds to physiotherapeutic intervention. It will help us to develop improved assessment procedures that can streamline patient management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
176

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 18, 2012

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

November 7, 2017

Status Verified

November 1, 2017

Enrollment Period

6 years

First QC Date

May 16, 2012

Last Update Submit

November 6, 2017

Conditions

Keywords

StressUrinaryIncontinencePelvicPhysiotherapy

Outcome Measures

Primary Outcomes (3)

  • Change in International Consultation on Incontinence Questionnaire: Female Lower Urinary Tract Symptoms (FLUTS)

    Changes in ICIQ FLUTS scores will be compared between treatment and control groups

    12 weeks before surgrey (TVT or TVT-O) to 12 weeks after surgery

  • Change in International Consultation on Incontinence Questionnaire - Short form score

    Changes in questionnaire scores will be compared between treatment and control groups

    12 weeks before surgery (TVT or TVT-O) to 12 weeks after surgery

  • Change in pad weight on a standardized 30 minute pad test

    Change in pad weight (in g) on a standardized pad test will be compared between the treatment and control groups

    12 weeks before surgery (TVT, TVT-O) to 12 weeks after surgery

Secondary Outcomes (1)

  • Change in International Consultation on Incontinence Questionnaire Quality of Life module score

    12 weeks before surgery (TVT, TVT-O) to 12 weeks after surgery

Study Arms (2)

Control

NO INTERVENTION

Participants in the control group will not receive therapist-supervised intervention. An exercise sheet briefly describing pelvic floor muscle exercises will be provided, as would be the standard practice from most physicians.

Pelvic Floor Therapy

EXPERIMENTAL

Participants in the experimental group undergo and assessment and treatment by a registered physiotherapist. Treatments will include two sessions of biofeedback training, therapist-assisted strengthening exercises, and will a prescribed home exercise program to strengthen their pelvic floor muscles.

Other: Pelvic Floor muscle strengthening exercises

Interventions

Participants will attend regular physical therapy visits (weekly X 2 weeks, bi-weekly X 4 weeks, and continuing monthly) until the time of their surgery. they will then see the physical therapist for assessment, exercise and advice at 2 and 4 weeks after their surgery. During physical therapy visits, patients will receive two sessions of biofeedback training, and at each visit will work on strength and motor control exercises for their pelvic floor muscles.

Also known as: Physical Therapy
Pelvic Floor Therapy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female
  • minimum age of 18
  • primary diagnosis of stress urinary incontinence by urogynaecologist
  • on the surgical wait list for surgery to address stress urinary incontinence

You may not qualify if:

  • currently pregnant or \<6 months post-partum
  • pelvic mass (es)
  • pad test weight gain less than 1g at baseline testing
  • no episode of SUI as demonstrated by a 3-day bladder diary
  • having received more than 4 sessions of physical therapy in the past 5 years specifically for treating their symptoms of SUI
  • detrusor instability as identified by routine urodynamics studies performed as part of the patient evaluation by the urogynaecologist
  • prolapse (\> POP-Q stage 2)
  • are taking medications known to increase or alleviate incontinence
  • not willing to cease other treatment for SUI treatment during the course of study
  • fecal incontinence (e.g., pessary)
  • prior urogynecological surgery to address urinary incontinence
  • neurological impairments involving the central nervous system or the sacral nerves or known connective tissue disorders
  • major psychiatric conditions which impact significantly with daily functioning and would prevent full participation in the study
  • physical impairment that would prevent the participant from completing the 20-minute pad test (a major study outcome measure)
  • in situ devices that would not be suitable for ultrasound testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Foothills Medical Centre

Calgary, Alberta, T2N 2T9, Canada

Location

School of Rehabilitation Therapy, Queen's University

Kingston, Ontario, K7L3N6, Canada

Location

The Ottawa Hospital

Ottawa, Ontario, K1Y 4E9, Canada

Location

Montfort Hospital

Ottawa, Ontario, Canada

Location

Related Publications (3)

  • Antonio FI, Yamamoto G, Varette K, McLean L. One in four women with stress urinary incontinence who are taught "the knack" maneuver adopt this motor pattern while coughing: A prospective interventional cohort study. Neurourol Urodyn. 2023 Aug;42(6):1290-1298. doi: 10.1002/nau.25196. Epub 2023 May 2.

  • McLean L, Charette M, Varette K, Brooks K, Harvey MA, Robert M, Baker K, Day A, Della Zazzera V, Sauerbrei E, Brison R. Pelvic floor muscle training as an adjunct to a midurethral sling: a single-blind randomised controlled trial. Int Urogynecol J. 2022 Apr;33(4):809-819. doi: 10.1007/s00192-020-04668-9. Epub 2021 Mar 3.

  • Brooks KCL, Varette K, Harvey MA, Robert M, Brison RJ, Day A, Baker K, Della Zazzera V, Sauerbrei E, McLean L. A model identifying characteristics predictive of successful pelvic floor muscle training outcomes among women with stress urinary incontinence. Int Urogynecol J. 2021 Mar;32(3):719-728. doi: 10.1007/s00192-020-04583-z. Epub 2020 Nov 25.

MeSH Terms

Conditions

Urinary Incontinence, Stress

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Linda McLean, PhD

    School Of Rehabilittion Therapy, Queen's University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 16, 2012

First Posted

May 18, 2012

Study Start

November 1, 2011

Primary Completion

November 1, 2017

Study Completion

November 1, 2017

Last Updated

November 7, 2017

Record last verified: 2017-11

Locations